Percutaneous absorption-type pharmaceutical preparation

Details Percutaneous absorption-type pharmaceutical preparation Percutaneous absorption-type pharmaceutical preparation

A - Human Necessities

61

K

A61K 31/137 (2006.01) A61K 9/70 (2006.01) A61K 47/30 (2006.01)

Patent

CA 2549516

A stable percutaneous absorption-type pharmaceutical preparation for percutaneous administration of selegiline or selegiline hydrochloride, which does not suffer a decrease in the cohesive force of the adhesive layer therein even in the presence of sweat components due to perspiration during wear and which is free from cohesive failure and resultant adhesive remaining when stripped off, is provided. A percutaneous absorption-type pharmaceutical preparation which comprises: a support; and an adhesive layer containing a metal chloride, an adhesive and at least one of (-)-(R)-N,.alpha.-dimethyl-N-2-propynylphenethylamine and its hydrochloride, wherein the adhesive layer is subjected to a crosslinking treatment.

Affiliated with

Also associated with

Rating

Percutaneous absorption-type pharmaceutical preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Percutaneous absorption-type pharmaceutical preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Percutaneous absorption-type pharmaceutical preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1445071